Clinical Trial Update: Nicotinamide Riboside for Diabetic Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating nicotinamide riboside for diabetic peripheral neuropathy has been terminated. The study was sponsored by the University of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Diabetic Neuropathy Peripheral | Phase 1, Phase 2 | Status: TERMINATED